WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.

Other languages Wanbangde Pharmaceutical Holding Group Co., Ltd.

Equities

002082

CNE000001P94

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 21/05/2024 am IST			5-day change	1st Jan Change
5.04 ^CNY	-0.79%		-2.51%	-21.25%

08/05	US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A	MT
29/04	Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A	08/05
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Wanbangde Pharmaceutical Holding Group Co., Ltd. Proposes Final Cash Dividend for the Year 2023	27/04
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04
Wanbangde Pharma Elects Vice Chairman, Appoints CFO	29/01
Wanbangde Pharma's Anesthesia Passes Drug Regulator's Consistency Evaluation	19/01
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Board Appointments	01/23/01
Wanbangde Pharmaceutical Registers New Medical Device	10/23/10
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023	31/23/31
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Cash Dividend for the Year 2022	18/23/18
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Profit Distribution Proposal for 2022	27/23/27
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/23/25
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma	26/22/26
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	13/22/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Wanbangde Pharmaceutical Holding Group Co., Ltd.

Equities

002082

CNE000001P94

Other languages

Filters